Bristol-Myers Squibb
BMY
BMY
2,588 hedge funds and large institutions have $116B invested in Bristol-Myers Squibb in 2022 Q4 according to their latest regulatory filings, with 263 funds opening new positions, 1,001 increasing their positions, 962 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,588
Holders Change
+132
Holders Change %
+5.37%
% of All Funds
41.76%
Holding in Top 10
75
Holding in Top 10 Change
-38
Holding in Top 10 Change %
-33.63%
% of All Funds
1.21%
New
263
Increased
1,001
Reduced
962
Closed
86
Calls
$2.26B
Puts
$1.82B
Net Calls
+$440M
Net Calls Change
+$28.5M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$2.55B |
| 2 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
$1.98B |
| 3 |
Boston Partners
Boston,
Massachusetts
|
$992M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$14.6B |
| 5 |
Citadel Advisors
Miami,
Florida
|
$222M |
